Sabrina Pengam - OSE Immunotherapeut, Nantes, France

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 22 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The IL-7R Antagonist Lusvertikimab Reduces Leukemic Burden in Xenograft-All Via Antibody-Dependent Cellular Phagocytosis

Lennart Lenk,Irene Baccelli,Anna Laqua,Julia Heymann, Claas Reimer,Anna Dietterle,Dorothee Winterberg,Caroline Mary,Frederique Corallo,Julien Taurelle, Emma Narbeburu,Stephanie Neyton,Mylene Derame,Sabrina Pengam,Fotini Vogiatzi,Beat Bornhauser,Jean-Pierre Bourquin,Simon Raffel, Vladyslava Dovhan,Thomas Schuler,Gabriele Escherich, Monique L. den Boer, Judith M. Boer,Wiebke Wessels,Matthias Peipp,Julia Alten,Zeljko Antic, Anke K. Bergmann,Martin Schrappe,Gunnar Cario,Monika Bruggemann,Nicolas Poirier,Denis M. Schewe

BLOOD（2024）

引用0浏览0WOS引用

First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Ra

Nicolas Poirier,Nicolas Poirier,Irene Baccelli,Lyssia Belarif, Riad Abes,Caroline Mary,Sonia Poli,Claudia Fromond,Isabelle Girault,Sabrina Pengam,Emilienne Soma, Fanny De Sa,Jean-Pascal Conduzorgues,Cecile Braudeau,Regis Josien,Bram Volckaert,Dominique Costantini,Frederique Corallo

Journal of immunology (Baltimore, Md. : 1950)no. 6 (2023): 753-763

引用0浏览0WOS引用

CLEC-1 inhibitory myeloid checkpoint blockade enhances antitumor responses and tumor phagocytosis by macrophages

Vanessa Gauttier,Irene Baccelli,Marion Drouin,Isabelle Girault,Sabrina Pengam,Emmanuelle Wilhelm,Javier Saenz,Julien Taurelle,Emmanuel Merieau,Berangere Evrard,Caroline Mary,Geraldine Teppaz,Ariane Desselle,Virginie Thepenier,Nicolas Poirier,Elise Chiffoleau

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract 6365: TRIM21 is a novel endogenous partner of the inhibitory myeloid checkpoint CLEC-1 involved in tumor antigen cross-presentation

Irène Baccelli,Vanessa Gauttier,Marion Drouin,Caroline Mary,Isabelle Girault,Emmanuelle Wilhelm,Sabrina Pengam,Géraldine Teppaz,Julien Taurelle,Ariane Desselle,Virginie Thépénier,Nicolas Poirier,Elise Chiffoleau

Cancer Researchno. 7_Supplement (2023): 6365-6365

引用0浏览0引用

Abstract 6358: CLEC-1 Inhibitory Myeloid Checkpoint Blockade Enhances Antitumor Responses and Tumor Phagocytosis by Macrophages

Vanessa Gauttier,Irène Baccelli,Marion Drouin,Isabelle Girault,Sabrina Pengam,Emmanuelle Wilhelm,Javier Saenz,Julien Taurelle,Emmanuel Mérieau,Bérangère Evrard,Caroline Mary,Géraldine Teppaz,Ariane Desselle,Virginie Thépénier,Nicolas Poirier,Elise Chiffoleau

Cancer researchno. 7_Supplement (2023): 6358-6358

引用0浏览0引用

TRIM21 is a novel endogenous partner of the inhibitory myeloid checkpoint CLEC-1 involved in tumor antigen cross-presentation

Irene Baccelli,Vanessa Gauttier,Marion Drouin,Caroline Mary,Isabelle Girault,Emmanuelle Wilhelm,Sabrina Pengam,Geraldine Teppaz,Julien Taurelle,Ariane Desselle,Virginie Thepenier,Nicolas Poirier,Elise Chiffoleau

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

484 Blockade of the Myeloid CLEC-1 Checkpoint Enhances Antitumor Responses and Tumor Antigen Cross-Presentation

Vanessa Gauttier,Marion Drouin,Isabelle Girault,Irene Baccelli,Sabrina Pengam,Emmanuelle Wilhelm,Javier Saenz,Julien Taurelle,Emmanuel Merieau,Berangere Evrard,Caroline Mary,Geraldine Teppaz,Ariane Desselle,Virginie Thepenier,Nicolas Poirier,Elise Chiffoleau

Regular and Young Investigator Award Abstracts (2022)

引用0浏览0引用

CLEC-1 is a Death Sensor That Limits Antigen Cross-Presentation by Dendritic Cells and Represents a Target for Cancer Immunotherapy

Science Advancesno. 46 (2022)

引用4浏览0WOSSCIENCE引用

230 Preclinical Efficacy of CLEC-1 Antagonist As Novel Myeloid Immune Checkpoint Therapy for Oncology

Vanessa Gauttier,Marion Drouin,Sabrina Pengam,Javier Saenz,Berangere Evrard,Stephanie Neyton,Caroline Mary,Geraldine Teppaz,Ariane Desselle,Virginie Thepenier,Emmanuelle Wilhelm,Nicolas Poirier,Elise Chiffoleau

Journal for immunotherapy of cancerno. Suppl 2 (2021): A245-A245

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn